Position in PHAT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$355,931
-$212,259 QoQ
Shares Held
32,037
-6.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $3,031,079,822 across 242 Biotechnology names. PHAT ranks #148 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in PHAT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $355,931 | 32,037 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $568,190 | 34,249 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $48,103 | 4,087 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $39,194 | 4,087 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $228,464 | 36,438 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $295,875 | 36,438 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $621,553 | 34,378 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $353,546 | 34,325 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $362,162 | 34,102 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $312,729 | 34,253 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $352,600 | 34,002 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $462,191 | 32,276 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $27,973 | 3,918 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $83,263 | 7,421 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $82,224 | 7,421 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $53,408 | 6,328 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $71,683 | 5,267 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $101,851 | 5,178 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $166,213 | 5,178 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $82,560 | 2,439 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $58,255 | 1,551 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $53,916 | 1,623 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $48,514 | 1,323 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $59,632 | 1,812 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $41,725 | 1,616 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||